Crossfund Sicav-Cross.M&M.Eq.F.A/ LU2208087424 /
| NAV7/23/2024 | Chg.-1.0600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 90.2400CHF | -1.16% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | - | -0.14 | 4.89 | 1.55 | -4.05 | 4.87 | -0.58 | -3.48 | 3.74 | -1.11 | 1.99 | - |
| 2022 | -2.39 | 3.63 | 3.80 | -4.42 | 2.41 | -17.13 | 3.05 | -0.03 | -5.49 | 2.27 | 16.50 | -4.10 | -5.25% |
| 2023 | 10.17 | -8.91 | 0.15 | -1.68 | -7.65 | 5.31 | 4.93 | -9.81 | -3.14 | -8.71 | 5.98 | 8.39 | -7.60% |
| 2024 | -8.83 | -5.42 | 10.67 | 6.75 | 2.78 | -7.19 | -3.10 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 21.66% | 21.79% | 22.60% | 21.65% | -% |
| Sharpe ratio | -0.64 | 0.38 | -0.71 | -0.41 | - |
| Best month | +10.67% | +10.67% | +10.67% | +16.50% | - |
| Worst month | -8.83% | -8.83% | -9.81% | -17.13% | - |
| Maximum loss | -15.48% | -15.48% | -22.77% | -29.81% | - |
| Outperformance | - | - | - | - | - |
All quotes in CHF
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 90.2400 | -12.22% | -14.71% | |
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 94.5300 | -10.06% | -11.21% | |
| Crossfund Sicav-Cross.M&M.Eq.F.A | reinvestment | 103.1500 | -7.82% | -3.69% | |
| Crossfund Sicav-Cross.M&M.Eq.F.D | reinvestment | 97.6800 | -6.92% | - |
Performance
| YTD | -5.85% | ||
|---|---|---|---|
| 6 Months | +5.84% | ||
| 1 Year | -12.22% | ||
| 3 Years | -14.71% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -11.83% | ||
| Year | |||
| 2023 | -7.60% | ||
| 2022 | -5.25% | ||
